hotspot -WSS

hotspot

author：entertainment 2025-09-27 22:32:11 - browse：88463

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： 'Patient friction coefficient' can gauge a clinical trial's patient burden

hotspot

WSS

Adam's Take: Intra

6 solutions to address cancer drug shortages and others

Readout Newsletter: Illumina, CRISPR, Regeneron

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Texas board proposes rules on abortion law emergency exemption

Erich Jarvis studies song birds to learn about human stuttering

explore

hotspot

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Pfizer, Moderna say biotech, pharma drug development is a sprint

Malaria cases in Florida and Texas: Here’s what you need to know

CRISPR base editing slashes cholesterol levels in monkeys

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The United States is paying nearly triple for new Covid vaccines

Duchenne breakthrough therapy leaves behind pioneering families

With Wegovy coverage, Medicare patients may face high costs

Continuity nursing helped my family in our darkest PICU moments

With Roe v Wade overturned, abortion providers work to adapt

explore

Setback for rare diseases as Taysha Gene Therapies pulls back

Bring on the sabbaticals for nurses

Texas board proposes rules on abortion law emergency exemption

RSV injection headlines need to be accurate for good uptake

This gene therapy has record $4.25 million price. It's saved children.

European officials brace for rough respiratory virus season

hotspot

hotspot

hotspot

explore